Induction of an immune response to breast cancer with MR-guided focused ultrasound tumor ablation in a mouse model

Project Name: Induction of an immune response to breast cancer with MR-guided focused ultrasound tumor ablation in a mouse model
Status: Complete
Primary Site: University of Washington
Funded Date: Dec 01, 2009
Funding Period: Dec 01, 2009 - Nov 30, 2011
Funding Program: Research Award
Category: Pre-Clinical
Amount Awarded: $100,000.00

Abstract

The purpose of this study is to test the ability of MR-guided Focused Ultrasound (MRgFU) to ablate breast adenocarcinoma in situ in a mouse model and induce a significant systemic and local anti-tumor immune response. Growing evidence indicates that ablation of cancer in vivo can cause immune stimulation and produce a potent anti-tumor response. An unmet need in the treatment of breast cancer is the reduction of morbidity, time and cost of chemotherapy and radiation therapy. We propose to address this problem by using MRgFU to ablate tumors in a mouse model of breast cancer and measure the immune response. The quantitative data from this study may provide an alternative treatment approach for breast cancer that is cheaper, faster and less toxic than current therapeutic options thereby accelerating FDA approval and implementation of MRgFU into clinical practice.

Contact Roles

Reports

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
434.220.4993
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Email